Fig. 3From: Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectumSubgroup analysis the effect of postoperative radiotherapy on rectal MC. The 5-year CSSs of patients in postoperative radiotherapy group and surgery alone group in: (a) stage II rectal MC, 93.3% vs. 76.6%, χ 2 = 4.654, P = 0.031, (b) stage III rectal MC, 67.5% vs. 64.7%, χ 2 = 0.186, P = 0.666Back to article page